Articles From: Acacia Subsidiary Enters into Patent License and Settlement Agreement with SAP America, Inc. to Acadia Realty Trust Announces Sale of 3.4 Million Common Shares


Acacia Research Corporation (NASDAQ: ACTG) announced today that its Data Engine Technologies LLC subsidiary has entered into a patent license and settlement agreement with SAP America, Inc. The agreement resolves litigation that was pending in the United States District Court for the Eastern District of Texas.
Sign-up for Acacia Subsidiary Enters into Patent License and Settlement Agreement with SAP America, Inc. investment picks
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Body Science LLC subsidiary has entered into a settlement agreement with A&D Engineering, Inc. regarding wireless medical diagnostic and monitoring systems.
Sign-up for Acacia Subsidiary Enters into Settlement Agreement with A&D Engineering, Inc. Regarding Wireless Medical Diagnosis and Monitoring Systems investment picks
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Bonutti Skeletal Innovations LLC subsidiary has entered into a settlement and patent license agreement with ConforMIS, Inc. The agreement resolves all aspects of the litigation for the United States District Court for the District of Delaware and the United States District Court for the District of Massachusetts.
Sign-up for Acacia Subsidiary Enters into Settlement and Patent License Agreement with ConforMIS, Inc. investment picks
Acacia Research Corporation (NASDAQ: ACTG) announced today that its LifeScreen Sciences LLC subsidiary has entered into a settlement and patent license agreement with Cordis Corporation.
Sign-up for Acacia Subsidiary Enters into Settlement and Patent License Agreement with Cordis Corporation investment picks
Acacia Research Corporation (NASDAQ:ACTG) announced today that its ADAPTIX, Inc. subsidiary entered into a settlement and patent license agreement with Huawei Technologies Co., Ltd.
Sign-up for Acacia Subsidiary Enters into Settlement and Patent License Agreement with Huawei Technologies Co., Ltd. investment picks
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Unified Messaging Solutions LLC subsidiary entered into a settlement and patent license agreement with Huntington Bancshares, Inc. The agreement resolves litigation that was pending in the United States District Court for the Northern District of Illinois.
Sign-up for Acacia Subsidiary Enters into Settlement and Patent License Agreement with Huntington Bancshares, Inc. investment picks
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Database Sync Solutions LLC subsidiary has entered into a settlement and patent license agreement with International Business Machines Corporation.
Sign-up for Acacia Subsidiary Enters into Settlement and Patent License Agreement with IBM investment picks
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Brandywine Communications Technologies LLC subsidiary entered into a settlement and patent license agreement with MegaPath Corporation.
Sign-up for Acacia Subsidiary Enters into Settlement and Patent License Agreement with MegaPath Corporation investment picks
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Cellular Communications Equipment LLC subsidiary has entered into a settlement and patent license agreement with NEC Corporation and its subsidiaries.
Sign-up for Acacia Subsidiary Enters into Settlement and Patent License Agreement with NEC Corporation investment picks
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Credit Card Fraud Control Corporation subsidiary has entered into a settlement and patent license agreement with TCSP Inc. dba TrustCommerce.
Sign-up for Acacia Subsidiary Enters into Settlement and Patent License Agreement with TCSP Inc. dba TrustCommerce investment picks
Acacia Research Corporation (NASDAQ: ACTG) announced today that its American Vehicular Sciences LLC subsidiary has entered into a settlement and patent license agreement with TomTom Inc. and TomTom International BV.
Sign-up for Acacia Subsidiary Enters into Settlement and Patent License Agreement with TomTom Inc. and TomTom International BV investment picks
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Parallel Separation Innovations LLC subsidiary entered into a Settlement and Release Agreement with Axiom Process, LLC and Axiom Process Ltd.
Sign-up for Acacia Subsidiary Enters into Settlement and Release Agreement with Axiom Process, LLC and Axiom Process Ltd investment picks
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Online News Link LLC subsidiary has entered into a settlement with Epsilon Data Management, LLC.
Sign-up for Acacia Subsidiary Enters into Settlement with Epsilon Data Management, LLC investment picks
Acacia Research Corporation (NASDAQ:ACTG) announced today that its Adaptix, Inc. subsidiary has entered into a settlement and patent license agreement with NEC Corporation and its subsidiaries for certain limited rights to the Adaptix patent portfolio.
Sign-up for Acacia Subsidiary Resolves Action with NEC Corporation investment picks
Acacia Research Corporation (NASDAQ: ACTG) announced today that a subsidiary has sourced rights in additional patent portfolios from Nokia Networks.
Sign-up for Acacia Subsidiary Sources from Nokia Networks Rights in Patent Portfolios for Wireless Technology investment picks
http://media.marketwire.com/attachments/200906/438886_oracleresized.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1168475&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for Academy Sports + Outdoors Implements Oracle Retail Solutions to Support Growth investment picks
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the third quarter and nine months ended September 30, 2014.
Sign-up for Acadia Healthcare Reports Third Quarter Adjusted Earnings Increase to $0.46 per Diluted Share on Revenue of $294.5 million investment picks
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) today announced the presentation of caregiver burden data from its Phase III program with NUPLAZID™ (pimavanserin) for Parkinson’s disease psychosis (PDP) at the 10 th Annual International Congress of Non-Motor Dysfunctions in Parkinson’s Disease and Related Disorders held from December 5-7 in Nice, France.
Sign-up for ACADIA Pharmaceuticals Presents Caregiver Burden Data at the International Congress of Non-Motor Dysfunctions in Parkinson’s Disease and Related Disorders investment picks
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in neurological and related central nervous system disorders, today announced its unaudited financial results for the third quarter ended September 30, 2014 and provided an update on the timing of its NUPLAZID™ (pimavanserin) New Drug Application (NDA) submission.
Sign-up for ACADIA Pharmaceuticals Reports Third Quarter 2014 Financial Results and Updates Timing of NUPLAZID™ NDA Submission investment picks
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2014 on Monday, November 10, 2014, after the U.S. financial markets close.
Sign-up for ACADIA Pharmaceuticals to Announce Third Quarter 2014 Financial Results on November 10, 2014 investment picks
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will present at the Jefferies 2014 Global Healthcare Conference on Thursday, November 20, 2014, at 9:20 a.m. GMT in London.
Sign-up for ACADIA Pharmaceuticals to Present at Jefferies 2014 Global Healthcare Conference on November 20, 2014 investment picks
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will present at the 33rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2015, at 11:30 a.m. Pacific Time in San Francisco.
Sign-up for ACADIA Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference on January 13, 2015 investment picks
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will present at the following investor conferences: Live webcasts of these presentations will be accessible on the company’s website, www.acadia-pharm.com , under the investors section and an archived recording will be available on the website for two weeks following the applicable presentation.
Sign-up for ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences investment picks
Acadia Realty Trust (NYSE:AKR) today announced the core-portfolio acquisition of an 88.4% interest in 840 N Michigan Ave, an 87,000 square foot, four-story street-retail property located in Chicago, Illinois, for $144.3 million.
Sign-up for Acadia Realty Trust Acquires Street Retail Flagship on Chicago’s Magnificent Mile investment picks
Acadia Realty Trust (NYSE: AKR), today announced a 4.3% increase in the Company’s dividend for the quarter ending December 31, 2014.
Sign-up for Acadia Realty Trust Announces 4.3% Increase in Quarterly Dividend and Anticipates Special Dividend for 2014 investment picks
Acadia Realty Trust (NYSE:AKR) (the “Company”) announced today the completion of its previously announced public offering of 3,400,000 common shares of beneficial interest (“Shares”), as well as the underwriters’ full exercise of their option to purchase an additional 510,000 Shares, bringing the total issuance to 3,910,000 Shares.
Sign-up for Acadia Realty Trust Announces Closing of Common Share Offering investment picks
2014/12/12
Acadia Realty Trust (NYSE: AKR - "Acadia" or the "Company") today announced that it expects to receive approximately $108.0 million in estimated gross proceeds from its sale of 3,400,000 common shares of beneficial interest (“Shares”) to Citigroup (or approximately $124.1 million if the option to purchase additional Shares is exercised in full). Citigroup acted as the sole bookrunner for the offering.
Sign-up for Acadia Realty Trust Announces Pricing of 3.4 Million Common Share Offering investment picks
2014/10/30
Acadia Realty Trust (NYSE:AKR - "Acadia" or the "Company") today announced that it expects to receive approximately $101.2 million in estimated gross proceeds from its sale of 3,400,000 common shares of beneficial interest (“Shares”) to BofA Merrill Lynch and Barclays (or approximately $116.3 million if the option to purchase additional Shares is exercised in full). BofA Merrill Lynch and Barclays acted as joint bookrunners for the offering.
Sign-up for Acadia Realty Trust Announces Pricing of 3.4 Million Common Share Offering investment picks
Acadia Realty Trust (NYSE:AKR)("Acadia" or the "Company") today announced the sale of 3,400,000 common shares of beneficial interest of the Company (“Shares”) to BofA Merrill Lynch and Barclays, in a public offering pursuant to the Company’s effective shelf registration statement previously filed with the Securities and Exchange Commission.
Sign-up for Acadia Realty Trust Announces Sale of 3.4 Million Common Shares investment picks
2014/12/11
Acadia Realty Trust (NYSE: AKR - "Acadia" or the "Company") today announced the sale of 3,400,000 common shares of beneficial interest of the Company (“Shares”) to Citigroup, in a public offering pursuant to the Company’s effective shelf registration statement previously filed with the Securities and Exchange Commission.
Sign-up for Acadia Realty Trust Announces Sale of 3.4 Million Common Shares investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Acacia Subsidiary Enters into Patent License and Settlement Agreement with SAP America, Inc. to Acadia Realty Trust Announces Sale of 3.4 Million Common Shares
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent